Versameb AG ("Versameb"), a clinical stage company focused on transforming RNA therapeutics to treat unmet medical needs, today announced the ...

Germinal centers are high-speed evolution machines. Tiny clusters in the lymph nodes, germinal centers refine antibodies through mutation and expansion until they produce high-affinity B cells adapted ...

A vaccine's ability to generate long-lasting, high-affinity antibodies hinges on a delicate balance. Upon exposure to a vaccine or pathogen, B cells scramble to refine their defenses, rapidly mutating ...

In an early-stage clinical trial, the therapy nearly doubled the expected survival time of young patients. Still, experts ...

Germinal centers are high-speed evolution machines. Tiny clusters in the lymph nodes, germinal centers refine antibodies ...

At a meeting with analysts and investors at its 2025 Investor Day, members of the leadership team of Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, will discuss ...

Adult antibody thresholds are currently used to determine whether immunocompromised children should get a measles, mumps, and rubella (MMR) booster shot. However, a new study shows that these ...

Preclinical pipeline re-prioritization to focus on four potentially transformative programs to advance toward clinic, led by CNTY-308 in B-cell ...

Study Spotlight: A 2022 study published in the Journal of Gastrointestinal Microbiology found that Bacillus Coagulans ...

Researchers are exploring materials like carbyne and borophene as stronger alternatives to graphene. Find out how these ...

The European Union on Wednesday outlined the steps that Apple must take to open up its iPhone and iPad operating systems to work better with competing technologies. It’s the first ...

Sera Prognostics Inc., The Pregnancy Company® , focused on improving maternal and neonatal health by providing innovative pregnancy biomarker information to doctors and patients, today announced ...